Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 4 , Pages 368-377 , April 2010

Familial Clustering and DRD4 Effects on Electroencephalogram Measures in Multiplex Families With Attention Deficit/Hyperactivity Disorder

  • Sandra K. Loo, Ph.D.

      Affiliations

    • Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at the University of California, Los Angeles
    • Corresponding Author InformationCorrespondence to: Dr. Loo, UCLA Semel Institute, Room 47-406, 760 Westwood Plaza, Los Angeles, CA 90095
    • ,
  • T. Sigi Hale, Ph.D.

      Affiliations

    • Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at the University of California, Los Angeles
    • ,
  • Grant Hanada, B.S.

      Affiliations

    • Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at the University of California, Los Angeles
    • ,
  • James Macion, B.A.

      Affiliations

    • Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at the University of California, Los Angeles
    • ,
  • Anshu Shrestha, M.P.H.

      Affiliations

    • Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at the University of California, Los Angeles
    • ,
  • James J. McGough, M.D.

      Affiliations

    • Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at the University of California, Los Angeles
    • ,
  • James T. McCracken, M.D.

      Affiliations

    • Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at the University of California, Los Angeles
    • ,
  • Stanley Nelson, M.D.

      Affiliations

    • Department of Human Genetics at the University of California, Los Angeles
    • ,
  • Susan L. Smalley, Ph.D.

      Affiliations

    • Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at the University of California, Los Angeles

,Accepted 19 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by grants from the National Institute of Child Health and Human Development (CD40275 to S.K.L.), the National Institutes of Neurological Disease and Stroke (NS054124 to S.K.L.) and National Institutes of Mental Health (MH058277 to S.L.S.).

 Disclosures: Dr. McGough consults and receives research support from Eli Lilly & Company, and Shire Pharmaceuticals. Dr. McCracken consults and receives research support from Bristol Myers Squibb, Aspect, Eli Lilly & Company, Wyeth, Sanofi-Aventis, and Pfizer. Drs. Loo, Hale, Shrestha, Nelson, and Smalley, and Mr. Hanada and Mr. Macion report no biomedical financial interests or potential conflicts of interest.

PII: S0890-8567(10)00076-6

doi: 10.1016/j.jaac.2010.01.002

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 4 , Pages 368-377 , April 2010

Article Tools

* Image Usage & Resolution